Hospitalization and Survival of Medicare Patients Treated With Carboplatin Plus Paclitaxel or Pemetrexed for Metastatic, Nonsquamous, Non–Small Cell Lung Cancer

IMPORTANCE: Chemotherapy is a mainstay treatment of metastatic non–small cell lung cancer. However, little is known about the comparative risk of hospitalization associated with commonly used chemotherapy regimens. OBJECTIVE: To evaluate the real-world association of specific lung cancer chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Gabriel A., Austin, Andrea M., Uno, Hajime, Dragnev, Konstantin H., Tosteson, Anna N. A., Schrag, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324452/
https://www.ncbi.nlm.nih.gov/pubmed/30646220
http://dx.doi.org/10.1001/jamanetworkopen.2018.3023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324452/
https://www.ncbi.nlm.nih.gov/pubmed/30646220
http://dx.doi.org/10.1001/jamanetworkopen.2018.3023

Ejemplares similares